Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial.

Tolaney SM, Tayob N, Dang C, Yardley DA, Isakoff SJ, Valero V, Faggen M, Mulvey T, Bose R, Hu J, Weckstein D, Wolff AC, Reeder-Hayes K, Rugo HS, Ramaswamy B, Zuckerman D, Hart L, Gadi VK, Constantine M, Cheng K, Briccetti F, Schneider B, Garrett AM, Marcom K, Albain K, DeFusco P, Tung N, Ardman B, Nanda R, Jankowitz RC, Rimawi M, Abramson V, Pohlmann PR, Van Poznak C, Forero-Torres A, Liu M, Ruddy K, Zheng Y, Rosenberg SM, Gelber RD, Trippa L, Barry W, DeMeo M, Burstein H, Partridge A, Winer EP, Krop I

Open source

DOI
10.1200/jco.20.03398
Published
2021 Jul 20
Container
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/jco.20.03398,
  title = {Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial.},
  author = {Tolaney SM and Tayob N and Dang C and Yardley DA and Isakoff SJ and Valero V and Faggen M and Mulvey T and Bose R and Hu J and Weckstein D and Wolff AC and Reeder-Hayes K and Rugo HS and Ramaswamy B and Zuckerman D and Hart L and Gadi VK and Constantine M and Cheng K and Briccetti F and Schneider B and Garrett AM and Marcom K and Albain K and DeFusco P and Tung N and Ardman B and Nanda R and Jankowitz RC and Rimawi M and Abramson V and Pohlmann PR and Van Poznak C and Forero-Torres A and Liu M and Ruddy K and Zheng Y and Rosenberg SM and Gelber RD and Trippa L and Barry W and DeMeo M and Burstein H and Partridge A and Winer EP and Krop I},
  year = {2021},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco.20.03398},
  url = {https://doi.org/10.1200/jco.20.03398}
}

RIS

TY  - JOUR
TI  - Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial.
AU  - Tolaney SM
AU  - Tayob N
AU  - Dang C
AU  - Yardley DA
AU  - Isakoff SJ
AU  - Valero V
AU  - Faggen M
AU  - Mulvey T
AU  - Bose R
AU  - Hu J
AU  - Weckstein D
AU  - Wolff AC
AU  - Reeder-Hayes K
AU  - Rugo HS
AU  - Ramaswamy B
AU  - Zuckerman D
AU  - Hart L
AU  - Gadi VK
AU  - Constantine M
AU  - Cheng K
AU  - Briccetti F
AU  - Schneider B
AU  - Garrett AM
AU  - Marcom K
AU  - Albain K
AU  - DeFusco P
AU  - Tung N
AU  - Ardman B
AU  - Nanda R
AU  - Jankowitz RC
AU  - Rimawi M
AU  - Abramson V
AU  - Pohlmann PR
AU  - Van Poznak C
AU  - Forero-Torres A
AU  - Liu M
AU  - Ruddy K
AU  - Zheng Y
AU  - Rosenberg SM
AU  - Gelber RD
AU  - Trippa L
AU  - Barry W
AU  - DeMeo M
AU  - Burstein H
AU  - Partridge A
AU  - Winer EP
AU  - Krop I
PY  - 2021
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco.20.03398
UR  - https://doi.org/10.1200/jco.20.03398
ER  -

APA

SM, T., N, T., C, D., DA, Y., SJ, I., V, V., M, F., T, M., R, B., J, H., D, W., AC, W., K, R., HS, R., B, R., D, Z., L, H., VK, G., M, C., K, C., F, B., B, S., AM, G., K, M., K, A., P, D., N, T., B, A., R, N., RC, J., M, R., V, A., PR, P., C, V. P., A, F., M, L., K, R., Y, Z., SM, R., RD, G., L, T., W, B., M, D., H, B., A, P., EP, W., & I, K. (2021). Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco.20.03398

Source records